Vein Graft Adaptation and Pathophysiology

When a segment of vein is repurposed as an arterial conduit, it is exposed to a surge in pressure and haemodynamic shear stress that drives profound remodelling. The endothelium sustains mechanical injury and activates inflammatory pathways, recruiting leukocytes and releasing chemokines. Under these conditions, vascular smooth muscle cells (VSMCs) switch from a quiescent contractile phenotype to a proliferative, migratory state, leading to neointimal hyperplasia and intimal thickening. Concurrent extracellular matrix deposition and adventitial remodelling further alter vessel geometry. Over months to years this maladaptive response may progress to accelerated atherosclerosis, calcification and graft occlusion. Understanding the balance between early adaptive wall thickening and chronic pathological remodelling is central to improving long-term patency of venous bypass grafts in coronary and peripheral revascularisation.

Research from Nature Portfolio

Acute exposure of saphenous vein endothelium to arterial‐level shear stress triggers rapid activation of the NF-κB transcription factor, elevating CCL2 production and monocyte adhesion within minutes. Targeted inhibition of NF-κB in ex vivo grafts prevents this early pro-inflammatory surge, suggesting a strategy for localized endothelial protection and reduced long‐term graft failure.

Deficiency of RP105, an accessory modulator of Toll-like receptor 4, intensifies inflammatory cell infiltration and unstable lesion formation in vein grafts within hypercholesterolaemic models. Loss of RP105 leads to elevated chemokine secretion by smooth muscle and mast cells, uncovering innate immunity as a critical driver of graft disease and a potential intervention point.

Vein Graft Adaptation and Pathophysiology publication trend

The graph below shows the total number of articles in vein graft adaptation and pathophysiology across all publications each year (not limited to Nature Index journals).

Technical terms

Neointimal hyperplasia: Pathological thickening of the vessel’s innermost layer due to proliferation and migration of vascular smooth muscle cells.

Shear stress: Frictional force exerted by flowing blood on endothelial cells that modulates gene expression and cellular behaviour.

Vascular smooth muscle cells (VSMCs): Contractile cells in the vessel wall that can switch phenotype, driving remodelling and hyperplasia.

Intimal thickening: Increase in thickness of the intima resulting from cellular proliferation and extracellular matrix accumulation.

References

1. Mechanical Activation of cPLA2 Impedes Fatty Acid β‐Oxidation in Vein Grafts. Advanced Science (2024).
2. Fhl1, a new spatially specific protein, regulates vein graft neointimal hyperplasia. Clinical and Translational Medicine (2024).
3. Inhibition of Intimal Thickening By PRH (Proline-Rich Homeodomain) in Mice. Arteriosclerosis Thrombosis and Vascular Biology (2023).
4. NF-κB inhibition prevents acute shear stress-induced inflammation in the saphenous vein graft endothelium. Scientific Reports (2020).
5. Deficiency of the TLR4 analogue RP105 aggravates vein graft disease by inducing a pro-inflammatory response. Scientific Reports (2016).